213 related articles for article (PubMed ID: 16001982)
21. Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.
Dedes KJ; Dedes I; Imesch P; von Bueren AO; Fink D; Fedier A
Anticancer Drugs; 2009 Jun; 20(5):321-33. PubMed ID: 19322073
[TBL] [Abstract][Full Text] [Related]
22. Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa.
Waterborg JH; Kapros T
Biochem Cell Biol; 2002; 80(3):279-93. PubMed ID: 12123281
[TBL] [Abstract][Full Text] [Related]
23. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
[TBL] [Abstract][Full Text] [Related]
24. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.
Li XN; Shu Q; Su JM; Perlaky L; Blaney SM; Lau CC
Mol Cancer Ther; 2005 Dec; 4(12):1912-22. PubMed ID: 16373706
[TBL] [Abstract][Full Text] [Related]
25. Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma.
Toh Y; Yamamoto M; Endo K; Ikeda Y; Baba H; Kohnoe S; Yonemasu H; Hachitanda Y; Okamura T; Sugimachi K
Oncol Rep; 2003; 10(2):333-8. PubMed ID: 12579268
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.
Bradbury CA; Khanim FL; Hayden R; Bunce CM; White DA; Drayson MT; Craddock C; Turner BM
Leukemia; 2005 Oct; 19(10):1751-9. PubMed ID: 16121216
[TBL] [Abstract][Full Text] [Related]
27. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
28. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
29. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.
Choudhury M; Shukla SD
Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
31. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
Karthik S; Sankar R; Varunkumar K; Ravikumar V
Biomed Pharmacother; 2014 Apr; 68(3):327-34. PubMed ID: 24485799
[TBL] [Abstract][Full Text] [Related]
32. Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.
Su JM; Li XN; Thompson P; Ou CN; Ingle AM; Russell H; Lau CC; Adamson PC; Blaney SM
Clin Cancer Res; 2011 Feb; 17(3):589-97. PubMed ID: 21115653
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
34. Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.
Suzuki J; Chen YY; Scott GK; Devries S; Chin K; Benz CC; Waldman FM; Hwang ES
Clin Cancer Res; 2009 May; 15(9):3163-71. PubMed ID: 19383825
[TBL] [Abstract][Full Text] [Related]
35. [Gender-dependent effects of histone deacetylase inhibitor sodium valproate on early olfactory learning in 129Sv mice].
Burenkova OV; Aleksandrova EA; Zaraĭskaia IIu
Ross Fiziol Zh Im I M Sechenova; 2013 Feb; 99(2):212-20. PubMed ID: 23650734
[TBL] [Abstract][Full Text] [Related]
36. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation.
Mai A; Massa S; Ragno R; Esposito M; Sbardella G; Nocca G; Scatena R; Jesacher F; Loidl P; Brosch G
J Med Chem; 2002 Apr; 45(9):1778-84. PubMed ID: 11960489
[TBL] [Abstract][Full Text] [Related]
37. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression.
Larsson P; Ulfhammer E; Magnusson M; Bergh N; Lunke S; El-Osta A; Medcalf RL; Svensson PA; Karlsson L; Jern S
PLoS One; 2012; 7(2):e31573. PubMed ID: 22363677
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain.
Im H; Grass JA; Christensen HM; Perkins A; Bresnick EH
Biochemistry; 2002 Dec; 41(51):15152-60. PubMed ID: 12484752
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.
Sami S; Höti N; Xu HM; Shen Z; Huang X
J Biochem; 2008 Sep; 144(3):357-62. PubMed ID: 18515856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
